Company: LRHC
Filing Date: 2025-08-22
Form Type: 424B3
Source: 0001213900-25-079984
Chunk: 25

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-22
Form: 424B3
Chunk 25
---
 shares of our common stock issuable upon the vesting of restricted stock units; and |

| ● | 2,428 shares of our common stock reserved for future issuance under our Second Amended and Restated 
 2022 Equity Incentive Plan.                                                                         |

<div align='center'>13

RISK FACTORS</div>

The risks and uncertainties described therein and below could materially adversely affect our business, operating results and financial condition, as well as cause the value of our securities to decline. You may lose all or part of your investment as a result. You should also refer to the other information contained in this Prospectus, or incorporated by reference, including our financial statements and the notes to those statements, and the information set forth under the caption “Special Note Regarding Forward-Looking Statements.” Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks mentioned below. Forward-looking statements included in this Prospectus are based on information available to us on the date hereof, and all forward-looking statements in documents incorporated by reference are based on information available to us as of the date of such documents. We disclaim any intent to update any forward-looking statements. The risks described below and contained in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and in our other periodic reports are not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business operations.

Risks Related to this Offering

The sale of the shares of common stock acquired by the Selling Stockholder, or the perception that such sales may occur, could cause the price of our common stock to decrease.

On August 4, 2025, we entered into the Facility
with the Selling Stockholder, pursuant to which the Selling Stockholder committed to purchase up to $150,000,000 of our common stock. The shares that we may issue and sell
to the Selling Stockholder under the Facility may be sold by us to the Selling Stockholder from time to time at our discretion over a 36-month period commencing on August 8,
2025. The purchase price for the shares that we may issue and sell to the Selling Stockholder under the Facility will vary based on the price of our common
stock at the time we initiate the sale. Depending on market liquidity at the time, sales of such shares may cause the trading price of
our common stock to decrease.

We generally have the right